Analyze Diet

Topic:West Nile Virus

West Nile Virus (WNV) is a mosquito-borne virus that affects horses, causing neurological disease. It is transmitted primarily through the bite of infected mosquitoes, which acquire the virus from feeding on infected birds. Horses are considered a dead-end host, meaning they do not contribute to the transmission cycle of the virus. Clinical signs in horses can range from mild fever and lethargy to severe neurological symptoms such as ataxia, weakness, and paralysis. Diagnosis is typically confirmed through serological testing or detection of the virus in tissues. Vaccination is available and serves as a preventive measure to reduce the incidence of the disease. This page compiles peer-reviewed research studies and scholarly articles that explore the epidemiology, pathogenesis, clinical presentation, and management of West Nile Virus in equine populations.
Monoclonal antibodies to equine IgM improve the sensitivity of West Nile virus-specific IgM detection in horses.
Veterinary immunology and immunopathology    December 3, 2007   Volume 122, Issue 1-2 46-56 doi: 10.1016/j.vetimm.2007.10.013
Wagner B, Glaser A, Hillegas JM, Erb H, Gold C, Freer H.West Nile virus (WNV) is a zoonotic pathogen of global importance. In horses with neurological signs, detection of WNV-specific immunoglobulin M (IgM) in serum is widely used to identify clinical cases of WNV encephalitis. Here, we describe the development of two monoclonal antibodies (mAbs) to equine IgM which were used in a WNV IgM-specific enzyme-linked immunosorbent assay (ELISA). Their performance was compared to an established assay based on polyclonal anti-IgM. Check test serum samples from the National Veterinary Service Laboratory (NVSL) were used to evaluate the performance of the th...
The relationship between equine and human West Nile virus disease occurrence.
Veterinary microbiology    November 29, 2007   Volume 129, Issue 3-4 378-383 doi: 10.1016/j.vetmic.2007.11.022
Ward MP, Scheurmann JA.Cases of human and equine West Nile virus (WNV) disease reported in Texas in 2002 were analyzed to assess their temporal relationship. For each human case with a known residential location, the closest equine case (within a 5 km radius) was selected. A total of 80 human-equine case pairs were identified, 51 (64%) of which were located in urban areas. Dates-of-onset of human and equine cases were positively correlated (r(SP)=0.494, P<0.001). Although overall there was no significant (P=0.207) difference between the dates-of-onset of human and equine cases, in urban areas of Texas equine case...
Seroprevalence and risk factors for infection with West Nile virus in Saskatchewan horses, 2003.
Canadian journal of veterinary research = Revue canadienne de recherche veterinaire    October 25, 2007   Volume 71, Issue 4 256-263 
Epp T, Waldner C, Leighton FA, Berke O, Townsend HG.The primary objectives of this study were to determine the seroprevalence of West Nile virus (WNV) infection of horses in Saskatchewan in 2003 and to identify risk factors for the infection. Blood samples were collected in August and October from 212 horses in 20 herds in 5 geographic zones. After accounting for within-herd clustering, the proportion of horses that had been infected with WNV, as determined by IgG and IgM antibody response, was 55.7% (95% confidence interval, 44.9% to 65.8%). The proportion of antibody-positive horses differed among herds (0% to 100%) and across ecoregions (20%...
Safety and efficacy in geese of a PER.C6-based inactivated West Nile virus vaccine.
Vaccine    October 15, 2007   Volume 25, Issue 49 8338-8345 doi: 10.1016/j.vaccine.2007.09.055
Samina I, Havenga M, Koudstaal W, Khinich Y, Koldijk M, Malkinson M, Simanov M, Perl S, Gijsbers L, Weverling GJ, Uytdehaag F, Goudsmit J.Studies were performed with an inactivated vaccine against the mosquito-borne flavivirus, West Nile virus (WNV). The mammalian cell line, PER.C6, was selected as the platform for WNV growth since both the neurovirulent strains NY99 and ISR98 that cause epidemics in humans and high mortality in geese, respectively, could be propagated to high titers (10(9) to 10(10)TCID(50)/ml) on these cells. Based on the high DNA homology of the WNV envelope (E) protein and non-structural protein 5 (NS5), and identical neurovirulence in mice and geese, we concluded that NY99 and ISR98 viruses are closely rela...
Using geographic information systems and spatial and space-time scan statistics for a population-based risk analysis of the 2002 equine West Nile epidemic in six contiguous regions of Texas.
International journal of health geographics    September 21, 2007   Volume 6 42 doi: 10.1186/1476-072X-6-42
Lian M, Warner RD, Alexander JL, Dixon KR.In 2002, West Nile virus (WNV) first appeared in Texas. Surveillance data were retrospectively examined to explore the temporal and spatial characteristics of the Texas equine WNV epidemic in 2002. Using Geographic Information Systems (GIS) and the Spatial and Space-Time Scan (SaTScan) statistics, we analyzed 1421 of the reported equine WNV cases from six contiguous state Health Service Regions (HSRs), comprising 158 counties, in western, northern, central and eastern Texas. Results: Two primary epidemic peaks occurred in Epidemiological (Epi) week 35 (August 25 to 31) and Epi week 42 (October...
West Nile virus outbreak detection using syndromic monitoring in horses.
Vector borne and zoonotic diseases (Larchmont, N.Y.)    September 5, 2007   Volume 7, Issue 3 403-410 doi: 10.1089/vbz.2006.0593
Leblond A, Hendrikx P, Sabatier P.Recent outbreaks of West Nile virus-associated (WNV) diseases, both in the old World and Americas, underline the importance for early warning systems that rapidly identify emerging and re-emerging diseases and thus help in their control. Traditional approaches of disease monitoring become less reliable and increasingly costly when used for rare health-related events, such as WNV outbreaks in southern France. The objective of this work was to discuss methodological issues related to syndromic monitoring of WNV-associated disease in Camargue horses by veterinary practitioners. Tracking cases of ...
Serosurvey of West Nile virus in equids and bovids in Spain.
The Veterinary record    August 19, 2007   Volume 161, Issue 6 212 doi: 10.1136/vr.161.6.212
Jiménez-Clavero MA, Tejedor CG, Rojo G, Soriguer R, Figuerola J.No abstract available
Comparative efficacies of three commercially available vaccines against West Nile Virus (WNV) in a short-duration challenge trial involving an equine WNV encephalitis model.
Clinical and vaccine immunology : CVI    August 8, 2007   Volume 14, Issue 11 1465-1471 doi: 10.1128/CVI.00249-07
Seino KK, Long MT, Gibbs EP, Bowen RA, Beachboard SE, Humphrey PP, Dixon MA, Bourgeois MA.We used a severe challenge model that produces clinical West Nile virus (WNV) disease to test the efficacy of three commercially available equine WNV vaccines in horses. Twenty-four healthy, WNV-seronegative horses of varying ages and genders were placed, in random and blind manner, into three trial groups consisting of eight horses each; two horses in each group received (i) an inactivated WNV vaccine (K-WN), (ii) a modified-live vaccine (CP-WN) containing the WNV prM and E proteins expressed by a canarypox vector, (iii) a live-chimera vaccine (WN-FV) containing WNV prM and E proteins express...
Epitope-blocking enzyme-linked immunosorbent assay to differentiate west nile virus from Japanese encephalitis virus infections in equine sera.
Clinical and vaccine immunology : CVI    June 27, 2007   Volume 14, Issue 8 1024-1031 doi: 10.1128/CVI.00051-07
Kitai Y, Shoda M, Kondo T, Konishi E.West Nile virus (WNV) is now widely distributed worldwide, except in most areas of Asia where Japanese encephalitis virus (JEV) is distributed. Considering the movement and migration of reservoir birds, there is concern that WNV may be introduced in Asian countries. Although manuals and guidelines for serological tests have been created in Japan in preparedness for the introduction of WNV, differential diagnosis between WNV and JEV may be complicated by antigenic cross-reactivities between these flaviviruses. Here, we generated a monoclonal antibody specific for the nonstructural protein 1 (NS...
[Presence of west Nile virus in northeast Mexico].
Salud publica de Mexico    June 26, 2007   Volume 49, Issue 3 210-217 doi: 10.1590/s0036-36342007000300006
Fernández-Salas I, de Lourdes Garza-Rodríguez M, Beaty BJ, Jiménez JR, Rivas-Estilla AM.To investigate the presence of WNV in birds, horses and humans in northeast Mexico. Methods: Serum samples from 33 birds, 24 horses and 237 humans were screened by ELISA for Anti-WNV antibodies. Human serum samples were also screened for WNV RNA using an RT-PCR assay. Results: Positive sera were found in three birds and 15 horses. Forty percent of the human serum samples were positive for IgG antibodies and 0% for IgM antibodies and viral RNA. Conclusions: The results of this study show that WNV is present in northeast Mexico and it is a new emergent infectious agent that represents a challeng...
Serological evidence for West Nile virus infection in horses in Croatia.
The Veterinary record    June 5, 2007   Volume 160, Issue 22 772-773 doi: 10.1136/vr.160.22.772
Madić J, Savini G, Di Gennaro A, Monaco F, Jukić B, Kovac S, Rudan N, Listes E.No abstract available
Experimental infections with West Nile virus.
Current opinion in infectious diseases    May 2, 2007   Volume 20, Issue 3 293-297 doi: 10.1097/QCO.0b013e32816b5cad
Bowen RA, Nemeth NM.West Nile virus emerged recently in North America as a serious human and animal pathogen. This review summarizes the use of experimental infections with West Nile virus in diverse vertebrate species that have been used to answer fundamental questions about the host response, pathogenesis of West Nile virus infection and virus evolution. Results: West Nile virus has an extremely broad vertebrate host range. Infection of common species of birds has defined those with high vs. low potential to serve as amplifying hosts for the virus. In general, mammals (primates, horses, companion animals) are d...
West Nile Virus in horses, sub-Saharan Africa.
Emerging infectious diseases    March 1, 2007   Volume 12, Issue 12 1958-1960 doi: 10.3201/eid1212.060042
Cabre O, Grandadam M, Marié JL, Gravier P, Prangé A, Santinelli Y, Rous V, Bourry O, Durand JP, Tolou H, Davoust B.To evaluate the presence and extension of West Nile virus where French soldiers are stationed in Africa, specific antibody prevalence was determined by using ELISA and Western blot. Among 245 horses living in close proximity to the soldiers, seroprevalence was particularly high in Chad (97%) and Senegal (92%).
Avian titer development against West nile virus after extralabel use of an equine vaccine.
Journal of zoo and wildlife medicine : official publication of the American Association of Zoo Veterinarians    February 28, 2007   Volume 36, Issue 2 257-264 doi: 10.1638/03-094.1
Johnson S.West Nile virus affects many animals, but the highest prevalence of morbidity and mortality is observed in birds, horses, and humans. The purpose of this study was to determine a protocol in birds of prey and corvids, using a vaccine developed for horses. The birds were assigned to five groups. Groups 1-4 received 0.25 ml, 0.5 ml, 0.75 ml, and 1.0 ml, respectively, and group 5 served as a control group. The greatest percentage of seroconversion (58.3%) was observed in the vaccine group that received a dose of 1.0 ml administered thrice, 3 wk apart. This report demonstrates that a vaccine devel...
Incidence and effects of West Nile virus infection in vaccinated and unvaccinated horses in California.
Veterinary research    February 6, 2007   Volume 38, Issue 1 109-116 doi: 10.1051/vetres:2006045
Gardner IA, Wong SJ, Ferraro GL, Balasuriya UB, Hullinger PJ, Wilson WD, Shi PY, MacLachlan NJ.A prospective cohort study was used to estimate the incidence of West Nile virus (WNV) infection in a group of unvaccinated horses (n = 37) in California and compare the effects of natural WNV infection in these unvaccinated horses to a group of co-mingled vaccinated horses (n = 155). Horses initially were vaccinated with either inactivated whole virus (n = 87) or canarypox recombinant (n = 68) WNV vaccines during 2003 or 2004, prior to emergence of WNV in the region. Unvaccinated horses were serologically tested for antibodies to WNV by microsphere immunoassay incorporating recombinant WNV E ...
West Nile virus in Europe and Africa: still minor pathogen, or potential threat to public health?
Bulletin de la Societe de pathologie exotique (1990)    January 27, 2007   Volume 99, Issue 5 348-354 
Couissinier-Paris P.Until 1999 the West Nile virus had been reported only in the "Old world" and particularly in Europe, Africa, Middle East and Asia where it was responsible only for sporadic or size-and-time-limited outbreaks in humans and equines. The sudden and unexpected emergence of WN in New York in 1999, followed by a rapid and huge extension to the whole North America in less than four years, made health authorities aware of the potential of previously forgotten viruses to become a threat to public health. The present review will focus on the epidemiology of West Nile virus in Europe and Africa during th...
Live-attenuated recombinant equine herpesvirus type 1 (EHV-1) induces a neutralizing antibody response against West Nile virus (WNV).
Virus research    January 22, 2007   Volume 125, Issue 1 69-78 doi: 10.1016/j.virusres.2006.12.009
Rosas CT, Tischer BK, Perkins GA, Wagner B, Goodman LB, Osterrieder N.The immunogenicity in horses of a recombinant equine herpesvirus type 1 (EHV-1) vaccine expressing West Nile virus (WNV) prM and E proteins was studied. To construct the recombinant EHV-1, two-step en passant mutagenesis was employed for manipulation of a bacterial artificial chromosome (BAC) of vaccine strain RacH. Recombinant EHV-1 stably expressed the WNV prM and E proteins as demonstrated by indirect immunofluorescence and Western blotting. In addition, growth properties in vitro of the EHV-1/WNV recombinant were found to not be significantly different from those of the parental virus. To ...
Experiences with new generation vaccines against equine viral arteritis, West Nile disease and African horse sickness.
Vaccine    January 16, 2007   Volume 25, Issue 30 5577-5582 doi: 10.1016/j.vaccine.2006.12.058
MacLachlan NJ, Balasuriya UB, Davis NL, Collier M, Johnston RE, Ferraro GL, Guthrie AJ.Viral diseases constitute an ever growing threat to the horse industry worldwide because of the rapid movement of large numbers of horses for competition and breeding. A number of different types of vaccines are available for protective immunization of horses against viral diseases. Traditional inactivated and live-attenuated (modified live virus, MLV) virus vaccines remain popular and efficacious but recombinant vaccines are increasingly being developed and used, in part because of the perceived deficiencies of some existing products. New generation vaccines include MLVs with deletions and/or...
West Nile virus in horses.
The Veterinary record    December 26, 2006   Volume 159, Issue 26 895 
Drummond R.No abstract available
West Nile virus: recent trends in diagnosis and vaccine development.
Vaccine    December 22, 2006   Volume 25, Issue 30 5563-5576 doi: 10.1016/j.vaccine.2006.12.005
Dauphin G, Zientara S.West Nile virus (WNV) is a mosquito-borne flavivirus, native to Africa, Europe, and Western Asia. In many respects, WNV is an outstanding example of a zoonotic pathogen that has leaped geographical barriers and can cause severe disease in human and horse. Before the emergence of WNV in the USA, only few methods of diagnosis were available. Recently, many changes in the fields of WN diagnosis and prevention have happened. This paper will review all these new tools. After a description of the main concerns in WNV and West Nile (WN) disease in humans and animals, this review will present the main...
West Nile virus isolation from equines in Argentina, 2006.
Emerging infectious diseases    December 21, 2006   Volume 12, Issue 10 1559-1561 doi: 10.3201/eid1210.060852
Morales MA, Barrandeguy M, Fabbri C, Garcia JB, Vissani A, Trono K, Gutierrez G, Pigretti S, Menchaca H, Garrido N, Taylor N, Fernandez F, Levis S....West Nile virus (WNV) was isolated from the brains of 3 horses that died from encephalitis in February 2006. The horses were from different farms in central Argentina and had not traveled outside the country. This is the first isolation of WNV in South America.
Remote sensing based identification of environmental risk factors associated with West Nile disease in horses in Camargue, France.
Preventive veterinary medicine    December 18, 2006   Volume 79, Issue 1 20-31 doi: 10.1016/j.prevetmed.2006.11.008
Leblond A, Sandoz A, Lefebvre G, Zeller H, Bicout DJ.Geographic information system and remote sensing technologies were used to identify landscape features associated with risk of West Nile virus transmission as defined by the presence of confirmed horse cases. SPOT-4 images of Camargue area were used to generate a map of landscape categories of epidemic foci and the geographic information system was employed to determine the proportion of landscape components surrounding 10 horse case sites and 17 control sites. The spatio-temporal analysis of the cases outbreak gave the best results for a spatial window of 9 km and a temporal window of 18 days...
West Nile virus in horses.
The Veterinary record    December 13, 2006   Volume 159, Issue 24 823 
Coumbe K, Mair T, Samuelson J, Sinclair D.No abstract available
West Nile virus in horses.
The Veterinary record    December 5, 2006   Volume 159, Issue 23 787-788 
Chandler K.No abstract available
Serological assessment of West Nile fever virus activity in the pastoral system of Ferlo, Senegal.
Annals of the New York Academy of Sciences    December 1, 2006   Volume 1081 216-225 doi: 10.1196/annals.1373.026
Chevalier V, Lancelot R, Diaité A, Mondet B, Sall B, De Lamballerie X.The Ferlo area (north-central Senegal) is characterized by a system of temporary ponds favorable to arboviruses among which West Nile fever (WNF) was already identified. During the rainy season in 2003, a serological study was undertaken on horses to assess the activity of the WNF virus (WNFV) in Barkedji (Ferlo). The observed serological prevalence rate was 78.3% for neutralizing antibodies, with a 95% confidence interval (CI) of [64.0, 92.7]. This prevalence rate significantly increased with age (P = 10(-5)). This study confirmed that WNF was endemic in the Ferlo. The transmission risks depe...
West Nile virus in Guadeloupe: introduction, spread, and decrease in circulation level: 2002-2005.
Annals of the New York Academy of Sciences    December 1, 2006   Volume 1081 206-215 doi: 10.1196/annals.1373.025
Lefrançois T, Blitvich BJ, Pradel J, Molia S, Vachiéry N, Martinez D.In July 2002, a surveillance system was implemented on Guadeloupe to detect for the potential introduction and monitor the spread of West Nile virus (WNV). From 2002 to 2004, equines and chickens were serologically assayed for antibodies to WNV by IgG and IgM enzyme-linked immunosorbent assay (ELISA), epitope-blocking ELISA, and plaque reduction neutralization tests. After introduction, probably through migratory birds at the end of 2001, many seroconversions occurred between July and October 2002 resulting in a high seroprevalence (19.3%) in equines in 2003. WNV circulation levels decreased d...
Monoclonal antibody-based competitive enzyme-linked immunosorbent assay for detecting and quantifying West Nile virus-neutralizing antibodies in horse sera.
Clinical and vaccine immunology : CVI    November 29, 2006   Volume 14, Issue 2 134-138 doi: 10.1128/CVI.00322-06
Choi KS, Ko YJ, Nah JJ, Kim YJ, Kang SY, Yoon KJ, Joo YS.A rapid immunoassay for detecting and quantifying West Nile virus (WNV)-neutralizing antibodies in sera was developed as an alternative to the plaque reduction neutralization test (PRNT), the gold standard test for WNV. The assay is a competitive, enzyme-linked immunosorbent assay using neutralizing monoclonal antibody 5E8 (NT-ELISA). A cutoff percent inhibition (PI) value of 35% (mean PI plus 3 standard deviations), with a specificity of 99%, was established based on analysis of 246 serum samples from horses free of WNV. The NT-ELISA detected neutralizing antibodies in all sera collected 7 or...
West Nile virus in horses.
The Veterinary record    November 23, 2006   Volume 159, Issue 21 723 doi: 10.1136/vr.159.21.723
Durham A.No abstract available
Control of arbovirus infections by a coordinated response: West Nile Virus in England and Wales.
FEMS immunology and medical microbiology    October 20, 2006   Volume 48, Issue 3 305-312 doi: 10.1111/j.1574-695X.2006.00159.x
Morgan D.Although there is no recognized transmission of human arboviral infections in the UK, concerns about the possible spread of West Nile virus (WNV) have precipitated coordinated activities around both surveillance and response. The Department of Health has chaired a UK WNV task force since the end of 2000. This is a multidisciplinary group of senior representatives from Agencies and Government Departments involved in human and animal health, entomology and academic departments. Activities include surveillance for WNV infections in humans, and in dead birds, mosquitoes and horses. All have been n...
The neutralizing antibody response against West Nile virus in naturally infected horses.
Virology    October 20, 2006   Volume 359, Issue 2 336-348 doi: 10.1016/j.virol.2006.08.047
Sánchez MD, Pierson TC, Degrace MM, Mattei LM, Hanna SL, Del Piero F, Doms RW.A major neutralizing epitope (here referred to as the T332 epitope) located on the lateral surface of domain III (DIII) of the West Nile virus (WNV) envelope protein has been identified based on the analysis of murine monoclonal antibodies. However, little is known about the humoral immune response against WNV in a natural host or whether DIII in general or the T332 epitope in particular are important targets of neutralizing antibodies in vivo. To characterize the types of antibodies produced during infection with WNV, we studied a group of naturally infected horses. Using immune adsorption as...
1 10 11 12 13 14 17